Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240278 · ClinicalTrials.gov registry record
Histology of Functional Density in Postmenopausal Breast
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 25
- Enrollment target
NCT01240278: Completed study, sponsored by Mayo Clinic.
NCT01240278 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01240278 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Increased mammographic density is recognized as an important risk factor for developing breast cancer, however, the underlying mechanism explaining this relationship is unclear. The investigators hypothesize that Molecular Breast Imaging (MBI) can more accurately distinguish dense tissue on mammography which is at high risk from dense tissue at low risk by indicating cellular activity in dense tissue as radiotracer uptake (functional density) in the breast. In this pilot study, the investigators want to compare the histological characteristics of breast tissue in patients with who have similar density on mammography but different levels of functional density on MBI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-11 |
| Est. Completion | 2022-04-27 |
What the finished NCT01240278 record still lists
NCT01240278 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01240278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01240278 about?
NCT01240278 is a clinical study titled "Histology of Functional Density in Postmenopausal Breast". Increased mammographic density is recognized as an important risk factor for developing breast cancer, however, the underlying mechanism explaining this relationship is unclear. The investigators hypothesize that Molecular Breast Imaging (MBI) can more accurately distinguish dense tissue on mammogra...
What is the current status of trial NCT01240278?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2010-11. Estimated completion is 2022-04-27.
Who is sponsoring clinical trial NCT01240278?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia